EODData

MEMBERSHIP REGISTER LOG IN

FRA, RB0: REGENXBIO Inc

04 Sep 2026
LAST:

7.820

CHANGE:
 0.31		OPEN:
7.820		HIGH:
7.820		ASK:
0.000		VOLUME:
0
CHG(%):
3.86		PREV:
8.134		LOW:
7.820		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Sep 267.8207.8207.8207.8200
03 Sep 268.1348.1348.1348.1340
02 Sep 267.9007.9007.9007.9000
31 Aug 268.2068.2068.2068.2060
28 Aug 268.4628.4628.2708.2700
27 Aug 267.9487.9487.9487.9480
26 Aug 267.5167.5167.5167.5160
25 Aug 266.8446.8446.8446.8440
24 Aug 269.0129.0129.0129.0120
21 Aug 269.3309.3309.3309.3300

PROFILE

Name:REGENXBIO Inc
About:REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
Sector:Healthcare
Industry:Biotechnology
Address:9804 Medical Center Drive, Rockville, MD, United States, 20850
Website:https://www.regenxbio.com
ISIN:US75901B1070
LEI:549300EOES47LATSET33

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.48 
Forward P/E:-2.15 
PEG Ratio:0.02 
Price to Sales:3.53 
Price to Book:8.22 
Profit Margin:-1.13 
Operating Margin:0.27 
Return on Assets:-0.21 
Return on Equity:-1.38 
Revenue:149.08M 
Shares:50.51M 
Market Cap:395.02M 

TECHNICAL INDICATORS

MA5:8.073.1%
MA10:8.103.6%
MA20:8.7211.5%
MA50:9.4621.0%
MA100:8.093.5%
MA200:8.8713.4%
STO9:45.02
STO14:29.17
RSI14:41.26
WPR14:-70.83
MTM14:-1.37
ROC14:-0.15 
ATR:0.53 
Week High:8.468.2%
Week Low:7.820.0%
Month High:10.1930.3%
Month Low:6.8413.4%
Year High:13.6073.9%
Year Low:4.7365.3%